Search

Your search keyword '"Mathiasen Anders B"' showing total 32 results

Search Constraints

Start Over You searched for: Author "Mathiasen Anders B" Remove constraint Author: "Mathiasen Anders B" Database OAIster Remove constraint Database: OAIster
32 results on '"Mathiasen Anders B"'

Search Results

1. Bone marrow-derived mesenchymal stromal cell treatment in patients with ischaemic heart failure:final 4-year follow-up of the MSC-HF trial

2. Overcoming the bottleneck of platelet lysate supply in large-scale clinical expansion of adipose-derived stem cells:A comparison of fresh versus three types of platelet lysates from outdated buffy coat-derived platelet concentrates

Catalog

Books, media, physical & digital resources

3. Experimental myocardial stem cell therapy for ST-elevation myocardial infarction:Rationale and level of evidence

4. Ultrastructural characterization of mesenchymal stromal cells labeled with ultrasmall superparamagnetic iron-oxide nanoparticles for clinical tracking studies

5. Quantification of myocardial perfusion using cardiac magnetic resonance imaging correlates significantly to rubidium-82 positron emission tomography in patients with severe coronary artery disease:A preliminary study

6. Quantification of myocardial perfusion using cardiac magnetic resonance imaging correlates significantly to rubidium-82 positron emission tomography in patients with severe coronary artery disease:A preliminary study

7. Left atrial volume and function in patients following ST elevation myocardial infarction and the association with clinical outcome:a cardiovascular magnetic resonance study

8. Value of cardiac 320-multidetector computed tomography and cardiac magnetic resonance imaging for assessment of myocardial perfusion defects in patients with known chronic ischemic heart disease

9. Direct intramyocardial mesenchymal stromal cell injections in patients with severe refractory angina - one year follow-up

10. Angiographic Features and Cardiovascular Risk Factors in Human Immunodeficiency Virus-Infected Patients With First-Time Acute Coronary Syndrome

11. Angiographic Features and Cardiovascular Risk Factors in Human Immunodeficiency Virus-Infected Patients With First-Time Acute Coronary Syndrome

12. Direct intramyocardial mesenchymal stromal cell injections in patients with severe refractory angina - one year follow-up

13. Left atrial volume and function in patients following ST elevation myocardial infarction and the association with clinical outcome:a cardiovascular magnetic resonance study

14. Value of cardiac 320-multidetector computed tomography and cardiac magnetic resonance imaging for assessment of myocardial perfusion defects in patients with known chronic ischemic heart disease

15. Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction

16. Myocardial area at risk after ST-elevation myocardial infarction measured with the late gadolinium enhancement after scar remodeling and T2-weighted cardiac magnetic resonance imaging

17. Plasma YKL-40 in relation to the degree of coronary artery disease in patients with stable ischemic heart disease

18. Myocardial area at risk and salvage measured by T2-weighted cardiovascular magnetic resonance: reproducibility and comparison of two T2-weighted protocols

19. Mesenchymal stromal cell derived endothelial progenitor treatment in patients with refractory angina

20. High-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: a prognostic study within the CLARICOR Trial

21. Myocardial area at risk after ST-elevation myocardial infarction measured with the late gadolinium enhancement after scar remodeling and T2-weighted cardiac magnetic resonance imaging

22. Plasma YKL-40 in relation to the degree of coronary artery disease in patients with stable ischemic heart disease

23. Myocardial area at risk and salvage measured by T2-weighted cardiovascular magnetic resonance: reproducibility and comparison of two T2-weighted protocols

24. Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction

25. Mesenchymal stromal cell derived endothelial progenitor treatment in patients with refractory angina

26. High-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: a prognostic study within the CLARICOR Trial

27. Myocardial area at risk after ST-elevation myocardial infarction measured with the late gadolinium enhancement after scar remodeling and T2-weighted cardiac magnetic resonance imaging

28. Plasma YKL-40 in relation to the degree of coronary artery disease in patients with stable ischemic heart disease

29. Myocardial area at risk and salvage measured by T2-weighted cardiovascular magnetic resonance: reproducibility and comparison of two T2-weighted protocols

30. Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction

31. Mesenchymal stromal cell derived endothelial progenitor treatment in patients with refractory angina

32. High-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: a prognostic study within the CLARICOR Trial